US$ 24.84
long term effects of glp 1 agonists Frontiers Glucagon-like Receptor-1 agonists for obesity:
Description
doi:10.1016/j.regpep.2006.02.007 5

A 1:1 propensity matching was also employed to account for confounders, including demographics, comorbidities, insulin use, and use of other second-line diabetic agents
Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients

The influence of GLP-1 analogs there can quickly spread throughout the brain, Skibicka says
